Abstract 2139P
Background
Long-term cancer survivors (LS), patients over 5 years free of disease, are a population on the rise due to oncological advances. Our aim is to explore QLACS in long-term cancer survival patients in Spain. As a secondary objective is to study their clinical and sociodemographic characteristics and their preference for social media or face-to-face meetings to obtain oncological information.
Methods
We carried out a transversal study in a sample of LS patients from several Spanish hospitals. They completed QLACS, FERREL, SPF12 and social media data. Different types of tumor were included. Psychometric properties of the QLACS were evaluated. Principal component analysis with Varimax rotation was applied to explore the dimensional structure. Pearson’s correlation (Pc) was used to study associations of QLACS with temporal variables. Student’s t test was used to study differences between them.
Results
N= 257, women=59,9 %, < 65 years=55%. Types Tumor: 33% breast, 27% colorectal, 8,9% urothelial, 7,4% other digestive tumors, 7% orl-lung. Factor analysis showed a 12-component solution accounts for 71.03 % of the variance, showing a similar comparable dimensional structure with QLACS. Alfa Cronbach=0,9. Appearance concern, distress over recurrence, pain, negative feelings and distress familiar are statistically higher in female (p<0,05). We found negative correlation between age and use of social networks for oncological information (Facebook: p = 0.01, Pc: -248; Twitter: p<0.04, Pc:- 200; Instagram: p <0.007, Pc: -259 except; Youtube: p = 0.17; Pc: -134). No differences by sex were observed in the use of social networks There were no differences by age in attending face-to-face meetings: p< 0.94, Pc: - 196. Breast cancer patients are more willing to attend face-to-face meetings to help other patients than those with colon cancer (p< 0.036).
Conclusions
QLACS is a valid and reliable instrument for measuring quality of life in long-term cancer survivors in Spain. Younger patients are more likely to use social media for oncology information. Older people tend to prefer face-to-face meetings. We found differences between men and women in different factors for measuring quality of life.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
M. Cornide.
Funding
Has not received any funding.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
2237P - Avelumab (AVE), cetuximab (CET) and irinotecan (IRI) for treatment refractory microsatellite stable (MSS) metastatic colorectal cancer (mCRC): Translational analyses of the AVETUXIRI phase II trial
Presenter: Nicolas Huyghe
Session: Poster session 07
2238P - Tebentafusp reprograms immunosuppressive tumor-associated M2 macrophages towards anti-tumoral M1 macrophages
Presenter: Josep M. Piulats
Session: Poster session 07
2239P - Gene expression profiling in tumors with and without tertiary lymphoid structures across cancer-types
Presenter: Elia Segui Solis
Session: Poster session 07
2240P - Novel genetic markers associated with immune checkpoint inhibitor induced immune-related adverse events
Presenter: Ik Shin Chin
Session: Poster session 07
2241P - A novel 89Zr-anti-PD-1 immuno-PET-CT may predict response to PD-1 inhibitors and improve response assessment in a lung cancer murine model receiving immunotherapy
Presenter: Ander Puyalto
Session: Poster session 07
2242P - Engineering immune-cell targeting nanoparticles for precise delivery of loaded-cargo and enhanced immunotherapy efficacy
Presenter: Na Kyeong Lee
Session: Poster session 07
2243P - Immune-modulating magnetic nanoparticles to enhance the immune response for the treatment of breast cancer metastasis and recurrence
Presenter: Jaesung Lim
Session: Poster session 07
2244P - Anti CTLA-4 and PD-1 monoclonal antibodies increases systemic SDF-1 and galectin-3 levels through NLRP3 and MyD-88 pathways in preclinical models
Presenter: Vincenzo Quagliariello
Session: Poster session 07
2245P - Graphene oxide: A promising platform for delivery of cancer immunotherapy
Presenter: Sorayut Chattrakarn
Session: Poster session 07
2246P - Tumor-infiltrating lymphocites and gene expression across multiple cancer-types: A translational analysis from the SOLTI-1904-ACROPOLI study
Presenter: Elia Segui Solis
Session: Poster session 07